$7.26 - CVKD | Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Cadrenal Therapeutics, Inc. Common Stock

XNAS:CVKD

7.26

-4.97%

Ask

$46.00 - 75.00

Bid

$6.50 - 1.00

Low

$7.07

High

$7.66

Open

$7.64

Prev Close

$7.64

52W High

22.9

52W Low

6.42

Volume

17600

Avg Vol (3m)

54339.8

Float

1814996.41

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 01/20/2023

Primary Exchange: XNAS

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Phone: 904-300-0701

Address: 822 A1a North

Address 2: Suite 306

City: Ponte Vedra

State: FL

Postal Code: 32082

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.910000

P/B (TTM)

5.753880

Round Lot

100

Composit FIGI

BBG019STRT20

Share Class FIGI

BBG019STRT39

Share Class Shares Outstanding

2.05M

Weighted Shares Outstanding

2.05M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion